TrialInternational journal of hematology2017

Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study.

Shigeki Kushimoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.